billprofit

336 results found.

Top Stocks matching your search for "bill profit"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 6, 2023

$AVXL thanks yet again Bill.

Dec, 9, 2022

Worth the risk with patience and not investing lif... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 3, 2023

$HKD buying more, too good of price to pass up

Feb, 1, 2023

$HKD just wait buddy we will pass competition very fast in next week

Image with triangles

Divihomes is Now Live

A new search platform that matches you with the best home improvement service providers in your area.

Instant Search & Match with Top Contractors

Instant Communication with Local Contractors

Phone Image with DiviHomes website

Millions of Unbiased User Reviews

100% Free Quotes from Top-Notch Contractors

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
KALA

Kala Pharmaceuticals Inc

-9.01%

$16.65 - $15.15

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 6, 2023

$AVXL thanks yet again Bill.

Dec, 9, 2022

Worth the risk with patience and not investing lifestyle or bill money.

Dec, 9, 2022

But, after cognition tests the trial passed all endpoints!

Dec, 9, 2022

THEN they said it hadnt passed any trials, well gee whiz now met BOTH secondary Endpoints. Newsflash.

Dec, 9, 2022

Blarcamesine passed every endpoints. .

Dec, 7, 2022

Key is we passed all endpoints with statically significant results!

Dec, 7, 2022

Hahah .. passed easily!

Dec, 3, 2022

Passed it all no problem!

Oct, 20, 2022

After TLR, Anavex will be the owner of a first-in-class, patented, medically-proven, high-demand asset that merely needs to pass through the technicality of government approval to qualify it for mass marketing.

HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 3, 2023

$HKD buying more, too good of price to pass up

Feb, 1, 2023

$HKD just wait buddy we will pass competition very fast in next week

Jan, 7, 2023

..pick me up or pass me whenever 💸💸💸💸💸💸💸💸💸💸💸💸💸💸💸💸🤑🤑🤑

Nov, 14, 2022

Hard to pass up this price !

KALA

Kala Pharmaceuticals Inc

-9.01%

$16.65 - $15.15

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.